A METHOD FOR QUANTIFYING BEVACIZUMAB
Brevet
Este ítem está publicado en
2017
Resumen en inglés
The present invention relates to the use of an Internal Standard compound in a method for quantifying Bevacizumab in a sample by mass spectrometry, wherein the said Internal Standard compound is described in the specification.
The present invention relates to the use of an Internal Standard compound in a method for quantifying Bevacizumab in a sample by mass spectrometry, wherein the said Internal Standard compound is described in the specification.< Leer menos
N° de patente
PCT/EP2016/072421Centros de investigación